Abstract: The present invention provides a passive inhaler for use in treating a number of diseases. The inventor has shown that the compositions comprised in the inhaler can be delivered to the lungs and to the brain in pharmacological relevant dosages, to treat a number of diseases in the lungs and the brain. Further, the inhaler is also able to deliver substances to the brain which may enhance transport across the blood brain barrier.
Type:
Grant
Filed:
August 25, 2015
Date of Patent:
October 24, 2023
Assignees:
CLK Consult v/Carsten Leonhard Knudsen CPR NO 020460-0457